Correlation Between Neximmune and CytomX Therapeutics
Can any of the company-specific risk be diversified away by investing in both Neximmune and CytomX Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Neximmune and CytomX Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Neximmune and CytomX Therapeutics, you can compare the effects of market volatilities on Neximmune and CytomX Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Neximmune with a short position of CytomX Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Neximmune and CytomX Therapeutics.
Diversification Opportunities for Neximmune and CytomX Therapeutics
0.0 | Correlation Coefficient |
Pay attention - limited upside
The 3 months correlation between Neximmune and CytomX is 0.0. Overlapping area represents the amount of risk that can be diversified away by holding Neximmune and CytomX Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on CytomX Therapeutics and Neximmune is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Neximmune are associated (or correlated) with CytomX Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of CytomX Therapeutics has no effect on the direction of Neximmune i.e., Neximmune and CytomX Therapeutics go up and down completely randomly.
Pair Corralation between Neximmune and CytomX Therapeutics
If you would invest (100.00) in Neximmune on December 30, 2024 and sell it today you would earn a total of 100.00 from holding Neximmune or generate -100.0% return on investment over 90 days.
Time Period | 3 Months [change] |
Direction | Flat |
Strength | Insignificant |
Accuracy | 0.0% |
Values | Daily Returns |
Neximmune vs. CytomX Therapeutics
Performance |
Timeline |
Neximmune |
Risk-Adjusted Performance
Very Weak
Weak | Strong |
CytomX Therapeutics |
Neximmune and CytomX Therapeutics Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Neximmune and CytomX Therapeutics
The main advantage of trading using opposite Neximmune and CytomX Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Neximmune position performs unexpectedly, CytomX Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in CytomX Therapeutics will offset losses from the drop in CytomX Therapeutics' long position.Neximmune vs. ZyVersa Therapeutics | Neximmune vs. Palisade Bio | Neximmune vs. Unicycive Therapeutics | Neximmune vs. Immix Biopharma |
CytomX Therapeutics vs. Spero Therapeutics | CytomX Therapeutics vs. Instil Bio | CytomX Therapeutics vs. NextCure | CytomX Therapeutics vs. Assembly Biosciences |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the AI Portfolio Architect module to use AI to generate optimal portfolios and find profitable investment opportunities.
Other Complementary Tools
Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
Headlines Timeline Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity | |
Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years | |
Portfolio Dashboard Portfolio dashboard that provides centralized access to all your investments | |
Content Syndication Quickly integrate customizable finance content to your own investment portal |